The FDA Approves Weight Loss Drug Zepbound, a Wegovy and Ozempic Rival

Science, Spoken - A podcast by WIRED

Podcast artwork

Eli Lilly is about to release Zepbound, a new entrant in the superheated competition for blockbuster weight loss drugs. Read this story here.

Visit the podcast's native language site